secwatch / observer
8-K filed July 9, 2025, 7:59 PM ET ticker FEED CIK 0001326706
other confidence high sentiment neutral materiality 0.15

NanoVibronix corrects typo in Series G preferred stock Floor Price to $1.91

ENvue Medical, Inc.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

ENvue Medical, Inc.: Certificate of Correction filed to fix a typographical error in the Floor Price definition in the Certificate of Designation for Series G Preferred Stock, changing it from $1.02 to $1.91 (effective 2025-07-08).

Change
charter amendment
Effective
2025-07-08
Exact text from the filing
On July 8, 2025, NanoVibronix, Inc. (the “ Company ”) filed with the Secretary of State of the State of Delaware, a certificate of correction (the “ Certificate of Correction ”) to the Company’s Certificate of Designation of the Preferences, Rights and Limitations of Series G Preferred Stock (the “ Certificate of Designations ”). The Certificate of Correction corrects an inadvertent typographical error in the definition of “Floor Price” in Section 1 of the Certificate of Designation, which should have been stated to be “$1.91” and was instead stated as “$1.02.”
View on SEC.gov

87 governance changes filed in the last 30 days. Browse all governance changes →

ENvue Medical, Inc. filing history →

Source: SEC EDGAR
accession 0001641172-25-018400
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.